Sagimet Biosciences Ownership 2024 | Who Owns Sagimet Biosciences Now?
Insider Ownership
14.11%
Sagimet Biosciences Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
BlackRock Health Sciences Trust II | 0.15% | 408,120 | 408,120 | - | Mar 31, 2024 |
BlackRock Health Sciences Trust | 0.09% | 21,965 | 21,965 | - | Mar 31, 2024 |
FIDELITY ADVISOR SERIES VII | 0.05% | 406,300 | - | - | Jan 31, 2024 |
BRIDGEWAY FUNDS INC | 0.02% | 45,000 | - | - | Mar 28, 2024 |
Federated Hermes Index Trust | 0.02% | 4,138 | - | - | Jan 31, 2024 |
FIDELITY MT VERNON STREET TRUST | 0.01% | 389,439 | -659,342 | -62.87% | Feb 29, 2024 |
FEDERATED HERMES INSURANCE SERIES | 0.01% | 24,000 | 4,000 | 20.00% | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,657 | 2,122 | 396.64% | Mar 31, 2024 |
FIDELITY SECURITIES FUND | 0.00% | 384,900 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 981,635 | 628,422 | 177.92% | Mar 31, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.00% | 1,198 | - | - | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.00% | 130,060 | 66,400 | 104.30% | Feb 29, 2024 |
Voya INVESTORS TRUST | 0.00% | 99,948 | 99,948 | - | Mar 31, 2024 |
Federated Hermes Equity Funds | 0.00% | 30,000 | -47,276 | -61.18% | Mar 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.00% | 9,109 | - | - | Mar 31, 2024 |
SEASONS SERIES TRUST | 0.00% | 33,318 | 33,318 | - | Mar 31, 2024 |
VICTORY PORTFOLIOS | 0.00% | 34,100 | 140 | 0.41% | Mar 31, 2024 |
BlackRock ETF Trust | 0.00% | 845 | 845 | - | Jan 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 14,259 | 13,237 | 1295.21% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 93,696 | 36,656 | 64.26% | Jan 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 12,562 | - | - | Jan 31, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,617 | 9,617 | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 56,685 | 1,076 | 1.93% | Feb 29, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,323 | 1,047 | 379.35% | Mar 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,600 | 11,100 | 444.00% | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 525 | - | - | Mar 31, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 84,080 | 84,080 | - | Mar 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 1,528 | 1,245 | 439.93% | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 8,961 | 6,344 | 242.41% | Mar 28, 2024 |
Global X Funds | 0.00% | 2,284 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 788,934 | 570,129 | 260.56% | Mar 31, 2024 |
BLACKROCK FUNDS | 0.00% | 302,930 | 302,930 | - | Feb 29, 2024 |
MUTUAL FUND SERIES TRUST | 0.00% | 185,000 | 185,000 | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 85,401 | 78,401 | 1120.01% | Mar 31, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,486 | 2,690 | 337.94% | Mar 31, 2024 |
ProFunds | 0.00% | 179 | 133 | 289.13% | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 16,203 | 5,241 | 47.81% | Mar 31, 2024 |
PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 402 | 402 | - | Feb 29, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 23,669 | 2,851 | 13.69% | Feb 29, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 982 | 443 | 82.19% | Jan 31, 2024 |
VALIC Co I | 0.00% | 2,131 | 61 | 2.95% | Feb 29, 2024 |
PACIFIC SELECT FUND | 0.00% | 23,535 | 21,373 | 988.58% | Mar 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 497 | - | - | Feb 29, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 14,707 | 11,489 | 357.02% | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 7,512 | 7,512 | - | Mar 31, 2024 |
PROSHARES TRUST | 0.00% | 813 | 119 | 17.15% | Feb 29, 2024 |
TIAA-CREF FUNDS | 0.00% | 7,575 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 629 | 18 | 2.95% | Jan 31, 2024 |
Bridge Builder Trust | 0.00% | 6,630 | 5,001 | 307.00% | Mar 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 2,737 | 2,024 | 283.87% | Mar 31, 2024 |
Sagimet Biosciences's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 408.12K shares, compromising 0.15% of its total assets.
Sagimet Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Sagimet Biosciences's stock was made by Kemble George on Jul 25 2024, selling 23,625 shares at $3.17 per share (valued at $74.83K). The last insider buy of SGMT was made by Happel David on Mar 28 2024, buying 12,100 shares at $5.27 per share (worth $63.73K).
Sagimet Biosciences Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 4 | - |
Q2 2024 | 8 | 1 | 800.00% |
Q1 2024 | 3 | 3 | 100.00% |
Q3 2023 | 5 | 18 | 27.78% |
Q1 2014 | - | 1 | - |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by Sagimet Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 4 | - |
Q2 2024 | - | - | - |
Q1 2024 | 1 | - | - |
Q3 2023 | 1 | 1 | 100.00% |
Q1 2014 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Sagimet Biosciences's stocks.